DEF 14A: NeuroPace, Inc. Announces Annual Meeting of Stockholders to Elect Directors and Ratify Accounting Firm
Proxy Statement
NeuroPace, Inc. will hold its Annual Meeting of Stockholders virtually on June 7, 2024, to elect Class III directors and ratify the selection of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm.
Summary
- NeuroPace, Inc. is holding its Annual Meeting of Stockholders on June 7, 2024, virtually.
- The meeting will include the election of three Class III directors: Uri Geiger, Rakhi Kumar, and Renee Ryan, each to hold office until the 2027 Annual Meeting.
- Stockholders will also vote to ratify the selection of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
- The Board of Directors recommends voting in favor of each director nominee and the ratification of the accounting firm.
- Stockholders of record as of April 10, 2024, are eligible to vote.
- The company intends to mail the Notice of Internet Availability of Proxy Materials on or about April 22, 2024.
- The Board of Directors knows of no other matters that will be presented for consideration at the Annual Meeting.
Sentiment
Score: 7
Explanation: The document is a standard proxy statement, which is generally neutral in tone. The recommendations from the board are positive, but overall the document is informational.
Positives
- The Board of Directors is recommending a vote in favor of all nominees and the ratification of the accounting firm, suggesting confidence in their abilities and performance.
- The virtual format of the Annual Meeting allows for greater participation from stockholders.
Future Outlook
The document outlines the procedures for the upcoming Annual Meeting and provides information for stockholders to make informed decisions regarding the election of directors and ratification of the accounting firm.
Industry Context
This proxy statement is a standard corporate governance document required for publicly traded companies, ensuring transparency and providing stockholders with the information needed to exercise their voting rights.
Stakeholder Impact
- Stockholders are directly impacted through their voting rights on key company decisions.
- The outcome of the director elections and accounting firm ratification can influence the company's governance and financial oversight.
Next Steps
- Stockholders should review the proxy materials and vote on the proposals.
- The company will hold the Annual Meeting on June 7, 2024.
- The company will file a Form 8-K to report the final voting results within four business days after the Annual Meeting.
Key Dates
| Date | Description |
|---|---|
| April 10, 2024 | Record date for determining stockholders eligible to vote at the Annual Meeting. |
| April 22, 2024 | Intended date for mailing the Notice of Internet Availability of Proxy Materials. |
| May 28, 2024 | Date from which the list of record stockholders will be available for examination. |
| June 6, 2024 | Deadline for internet and telephone votes (8:59 p.m. Pacific time). |
| June 7, 2024 | Date of the Annual Meeting of Stockholders at 10:30 a.m. Pacific time. |
| December 24, 2024 | Deadline for submitting stockholder proposals for inclusion in the next year's proxy materials. |
| February 7, 2025 | Earliest date for submitting a proposal (including a director nomination) at the meeting that is not to be included in next year’s proxy materials. |
| March 9, 2025 | Latest date for submitting a proposal (including a director nomination) at the meeting that is not to be included in next year’s proxy materials. |
| April 8, 2025 | Deadline for stockholders who intend to solicit proxies in support of director nominees other than our nominees to provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act. |
Keywords
Annual Meeting, Proxy Statement, Board of Directors, Stockholders, Director Election, Accounting Firm, PricewaterhouseCoopers, Corporate Governance, Voting, NeuroPace
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.